Joy Wolfram | |
---|---|
Born | 1989 (age 34–35) Finland |
Alma mater | University of Helsinki (Bachelor's & Master's) University of the Chinese Academy of Sciences (PhD) |
Scientific career | |
Fields | Nanomedicine Nanotechnology Nanoparticle drug delivery Biotechnology Medical diagnosis |
Institutions | Mayo Clinic Houston Methodist Hospital University of North Florida University of Queensland |
Joy Wolfram (born 1989) is a Finnish nanoscientist.[1][2] She is known for her pioneering work in nanomedicine concerning the treatment of cancer,[3] cardiovascular diseases and other life-threatening illnesses. [4][5] She is an Associate Professor at the University of Queensland, in the school of Chemical Engineering and the Australian Institute for Bioengineering and Nanotechnology.[1][2] She was the forefront of the Extracellular Vesicles and Nanomedicine laboratory at Mayo Clinic.[6] She is also an affiliate faculty member at Houston Methodist Hospital's Department of Nanomedicine. Wolfram sits as a scientific advisor and as a board member of several biotechnology companies around the world.[7]